Business Description
Envoy Medical Inc
NAICS : 423450
SIC : 3845
ISIN : US29415V1171
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.51 | |||||
Equity-to-Asset | -0.23 | |||||
Debt-to-Equity | -0.32 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -53.75 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.03 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 652.03 | |||||
Days Sales Outstanding | 105.44 | |||||
Days Payable | 1001.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 17.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -217.65 | |||||
Operating Margin % | -6134.45 | |||||
Net Margin % | -6959.66 | |||||
ROA % | -182.07 | |||||
ROIC % | -597.26 | |||||
ROC (Joel Greenblatt) % | -1358.14 | |||||
ROCE % | -618.32 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 362.5 | |||||
EV-to-EBIT | -5.59 | |||||
EV-to-EBITDA | -5.62 | |||||
EV-to-Revenue | 342.87 | |||||
EV-to-FCF | -4.58 | |||||
Earnings Yield (Greenblatt) % | -17.89 | |||||
FCF Yield % | -20.89 |